Remoxipride: pharmacokinetics and effect on plasma prolactin (Q34358692)

From Wikidata

Revision as of 01:05, 29 October 2022 by Cewbot (talk | contribs) (‎Added reference to claim: main subject (P921): pharmacology (Q128406), Modify PubMed ID: 1685665 citation data from NCBI, Europe PMC and CrossRef)

(diff) ← Older revision | Latest revision (diff) | Newer revision → (diff)

Jump to navigation Jump to search

scientific article published on September 1, 1991

Language	Label	Description	Also known as
English	Remoxipride: pharmacokinetics and effect on plasma prolactin	scientific article published on September 1, 1991

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

1 August 2017

Remoxipride: pharmacokinetics and effect on plasma prolactin (English)

1 reference

Europe PubMed Central

PubMed publication ID

1 August 2017

pharmacokinetics

1 reference

based on heuristic

inferred from title

1 reference

10.1111/J.1365-2125.1991.TB03911.X

https://api.crossref.org/works/10.1111/J.1365-2125.1991.TB03911.X

29 October 2022

author name string

Movin-Osswald G

1

1 reference

Europe PubMed Central

PubMed publication ID

1 August 2017

Hammarlund-Udenaes M

2

1 reference

Europe PubMed Central

PubMed publication ID

1 August 2017

G. Movin-Osswald

1

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A1685665

29 October 2022

M. Hammarlund-Udenaes

2

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A1685665

29 October 2022

language of work or name

0 references

publication date

1 September 1991

1 reference

Europe PubMed Central

PubMed publication ID

1 August 2017

full work available at URL

https://europepmc.org/articles/PMC1368530

online access status

content deliverer

Europe PubMed Central

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A1685665

29 October 2022

https://europepmc.org/articles/PMC1368530?pdf=render

Portable Document Format

online access status

content deliverer

Europe PubMed Central

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A1685665

29 October 2022

https://api.wiley.com/onlinelibrary/tdm/v1/articles/10.1111%2Fj.1365-2125.1991.tb03911.x

1 reference

10.1111/J.1365-2125.1991.TB03911.X

https://api.crossref.org/works/10.1111/J.1365-2125.1991.TB03911.X

29 October 2022

http://onlinelibrary.wiley.com/wol1/doi/10.1111/j.1365-2125.1991.tb03911.x/fullpdf

1 reference

10.1111/J.1365-2125.1991.TB03911.X

https://api.crossref.org/works/10.1111/J.1365-2125.1991.TB03911.X

29 October 2022

British Journal of Clinical Pharmacology

1 reference

Europe PubMed Central

PubMed publication ID

1 August 2017

32

1 reference

Europe PubMed Central

PubMed publication ID

1 August 2017

3

1 reference

Europe PubMed Central

PubMed publication ID

1 August 2017

355-360

1 reference

Europe PubMed Central

PubMed publication ID

1 August 2017

Remoxipride, a new potential antipsychotic compound with selective antidopaminergic actions in the rat brain

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1368530

6 July 2018

Prolactin-Lowering and -Releasing Drugs Mechanisms of Action and Therapeutic Applications

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1368530

6 July 2018

Effect of urinary pH on the plasma and urinary kinetics of remoxipride in man.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1368530

6 July 2018

Remoxipride--a new potential antipsychotic compound. Tolerability and pharmacokinetics after single oral and intravenous administration in healthy male volunteers

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1368530

6 July 2018

Safety evaluation in both short- and long-term treatment of schizophrenia with remoxipride.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1368530

6 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1368530

6 July 2018

CLINICAL CALORIMETRY

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2125.1991.TB03911.X

21 January 2018

Remoxipride ? a new potential antipsychotic compound

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2125.1991.TB03911.X

21 January 2018

Neuroendocrine responses to single oral doses of remoxipride and sulpiride in healthy female and male volunteers

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2125.1991.TB03911.X

21 January 2018

Clinical profile of remoxipride--a combined analysis of a comparative double-blind multicentre trial programme

1 reference

https://pubmed.ncbi.nlm.nih.gov/1685665

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

A controlled dose-ranging study of remoxipride and haloperidol in schizophrenia--a Canadian multicentre trial

1 reference

https://pubmed.ncbi.nlm.nih.gov/1685665

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Determination of remoxipride in plasma and urine by reversed-phase column liquid chromatography

1 reference

https://pubmed.ncbi.nlm.nih.gov/1685665

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Remoxipride--a new potential antipsychotic drug. Pharmacological effects and pharmacokinetics following repeated oral administration in male volunteers

1 reference

https://pubmed.ncbi.nlm.nih.gov/1685665

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Steady-state pharmacokinetics of controlled release and immediate release formulations of remoxipride in patients with chronic schizophrenia

1 reference

https://pubmed.ncbi.nlm.nih.gov/1685665

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Identifiers

10.1111/J.1365-2125.1991.TB03911.X

1 reference

Europe PubMed Central

PubMed publication ID

1 August 2017

PMC publication ID

1 reference

Europe PubMed Central

PubMed publication ID

1 August 2017

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

1 August 2017

ResearchGate publication ID

0 references

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q34358692&oldid=1760208565"